SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00037



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00037_201703011_QEh1_LC2_FaMaChCh_SA_HLApI_3865-DM 1 Human HLA-A01:01,HLA-A03:01,HLA-B35:01,HLA-B57:01,HLA-C04:01,HLA-C06:02
SYSMHC00037_201703020_QEh1_LC2_FaMaChCh_SA_HLApII_3865-DM 1 Human DRB1_0101,DRB1_0701
SYSMHC00037_20170302_QEh1_LC2_FaMa_ChCh_SA_HLApI_RA957 6 Human HLA-A02:20,HLA-A68:01,HLA-B35:03,HLA-B39:01,HLA-C04:01,HLA-C07:02
SYSMHC00037_20170303_QEh1_LC2_FaMa_ChCh_SA_HLApI_CD165 3 Human HLA-A02:05,HLA-A24:02,HLA-B15:01,HLA-B50:01,HLA-C03:03,HLA-C06:02
SYSMHC00037_20170303_QEh1_LC2_FaMa_ChCh_SA_HLApI_CM647 3 Human HLA-A01:01,HLA-A24:02,HLA-B13:02,HLA-B39:06,HLA-C06:02,HLA-C12:03
SYSMHC00037_20170303_QEh1_LC2_FaMa_ChCh_SA_HLApI_JY 3 Human HLA-A02:01,HLA-B07:02,HLA-C07:02
SYSMHC00037_20170303_QEh1_LC2_FaMa_ChCh_SA_HLApI_PD42 3 Human HLA-A02:06,HLA-A24:02,HLA-B07:02,HLA-B55:01,HLA-C01:02,HLA-C07:02
SYSMHC00037_20170303_QEh1_LC2_FaMa_ChCh_SA_HLApI_TIL1 3 Human HLA-A02:01,HLA-B18:01,HLA-B38:01,HLA-C05:01
SYSMHC00037_20170306_QEh1_LC2_FaMa_ChCh_SA_HLApI_TIL3 3 Human HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02
SYSMHC00037_20170311_QEh1_LC2_FaMaChCh_SA_HLApI_3849-BR 2 Human HLA-A01:01,HLA-A31:01,HLA-B38:01,HLA-B44:02,HLA-C05:01,HLA-C12:03
SYSMHC00037_20170311_QEh1_LC2_FaMaChCh_SA_HLApI_3912-BAM 1 Human HLA-A01:01,HLA-A29:06,HLA-B08:01,HLA-B15:01,HLA-C03:04,HLA-C07:01
SYSMHC00037_20170317_QEh1_LC2_FaMa_ChCh_SA_HLApII_CD165 3 Human DRB1_1101
SYSMHC00037_20170317_QEh1_LC2_FaMa_ChCh_SA_HLApII_CM647 3 Human DRB1_0701,DRB1_1601
SYSMHC00037_20170317_QEh1_LC2_FaMa_ChCh_SA_HLApII_PD42 3 Human DRB1_0102,DRB1_1501
SYSMHC00037_20170317_QEh1_LC2_FaMa_ChCh_SA_HLApII_RA957 3 Human DRB1_0401,DRB1_0801
SYSMHC00037_20170317_QEh1_LC2_FaMa_ChCh_SA_HLApII_TIL1 3 Human DRB1_0101,DRB1_0408
SYSMHC00037_20170317_QEh1_LC2_FaMa_ChCh_SA_HLApII_TIL3 3 Human DRB1_1201,DRB1_1501
SYSMHC00037_20170320_QEh1_LC2_FaMaChCh_SA_HLApII_3830-NJF 3 Human DRB1_0404,DRB1_1101
SYSMHC00037_20170320_QEh1_LC2_FaMaChCh_SA_HLApII_3849-BR 2 Human DRB1_1104
SYSMHC00037_20170320_QEh1_LC2_FaMaChCh_SA_HLApII_3912-BAM 1 Human DRB1_1104
SYSMHC00037_20170320_QEh1_LC2_FaMaChCh_SA_HLApI_3830-NJF 3 Human HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02
SYSMHC00037_20170320_QEh1_LC2_FaMa_ChCh_SA_HLApII_JY 3 Human DRB1_0404,DRB1_1301
SYSMHC00037_20170402_QEh1_LC1_FaMaChCh_SA_CD165_10M 3 Human HLA-A02:05,HLA-A24:02,HLA-B15:01,HLA-B50:01,HLA-C03:03,HLA-C06:02
SYSMHC00037_20170402_QEh1_LC1_FaMaChCh_SA_CD165_30M 3 Human HLA-A02:05,HLA-A24:02,HLA-B15:01,HLA-B50:01,HLA-C03:03,HLA-C06:02
SYSMHC00037_20170402_QEh1_LC1_FaMaChCh_SA_CD165_50M 3 Human HLA-A02:05,HLA-A24:02,HLA-B15:01,HLA-B50:01,HLA-C03:03,HLA-C06:02
SYSMHC00037_20170403_QEh1_LC1_FaMaChCh_SA_HLApII_CD165_10M 3 Human DRB1_1101
SYSMHC00037_20170403_QEh1_LC1_FaMaChCh_SA_HLApII_CD165_70M 3 Human DRB1_1101
SYSMHC00037_20170405_QEh1_LC1_FaMaChCh_SA_HLApII_CD165_30M 3 Human DRB1_1101
SYSMHC00037_20170413_QEh1_LC2_ChC_FaMa_SA_HLApII_CD165_50M 6 Human DRB1_1101
SYSMHC00037_20170413_QEh1_LC2_ChC_FaMa_SA_HLApI_CD165_70M 3 Human HLA-A02:05,HLA-A24:02,HLA-B15:01,HLA-B50:01,HLA-C03:03,HLA-C06:02
SYSMHC00037_20170608_QEh1_LC1_ChCh_FAMA_SA_HLAIp_UWB1289_IFNg 4 Human HLA-A03:01,HLA-A68:01,HLA-B07:02,HLA-B07:02,HLA-C03:32,HLA-C07:02
SYSMHC00037_20170608_QEh1_LC1_ChCh_FAMA_SA_HLAIp_UWB1289_ctrl 4 Human HLA-A03:01,HLA-A68:01,HLA-B07:02,HLA-B07:02,HLA-C03:32,HLA-C07:02
SYSMHC00037_20170609_QEh1_LC1_ChCh_FAMA_SA_HLApII_JY 3 Human DRB1_0404,DRB1_1301
SYSMHC00037_20170609_QEh1_LC1_ChCh_FAMA_SA_HLApI_JY 3 Human HLA-A02:01,HLA-B07:02,HLA-C07:02



Detailed view of sample SYSMHC00037_20170320_QEh1_LC2_FaMaChCh_SA_HLApI_3830-NJF



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00037 SYSMHC00037_20170320_QEh1_LC2_FaMaChCh_SA_HLApI_3830-NJF 20170320_QEh1_LC2_FaMaChCh_SA_HLApI_3830-NJF_2_R1.raw Human In vitro Blood Lymphoblast cell suspension class I HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02 29242379 native Immunoaffinity W6/32 Q-Exactive HF nanoflow UHPLC Easy nLC 1200 no DDA HCD 1
SYSMHC00037 SYSMHC00037_20170320_QEh1_LC2_FaMaChCh_SA_HLApI_3830-NJF 20170320_QEh1_LC2_FaMaChCh_SA_HLApI_3830-NJF_1_R1.raw Human In vitro Blood Lymphoblast cell suspension class I HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02 29242379 native Immunoaffinity W6/32 Q-Exactive HF nanoflow UHPLC Easy nLC 1200 no DDA HCD 2
SYSMHC00037 SYSMHC00037_20170320_QEh1_LC2_FaMaChCh_SA_HLApI_3830-NJF 20170320_QEh1_LC2_FaMaChCh_SA_HLApI_3830-NJF_3_R1.raw Human In vitro Blood Lymphoblast cell suspension class I HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02 29242379 native Immunoaffinity W6/32 Q-Exactive HF nanoflow UHPLC Easy nLC 1200 no DDA HCD 3